SCHEMBL1533754

SCHEMBL1533754

CCCc1ccc(-c2ccc(-c3ccc(F)s3)c(F)c2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RARB P10826 3/20 0.40
▸ RARA P10276 1/20 0.40
▸ RARG P13631 1/20 0.40
▸ MCL1 Q07820 1/20 0.38
▸ ESR1 P03372 2/20 0.36
▸ ESR2 Q92731 2/20 0.36
▸ NPC1 O15118 2/20 0.35
▸ MAPT P10636 2/20 0.35
▸ RAB9A P51151 2/20 0.35
▸ ALOX5 P09917 2/20 0.35
▸ GFER P55789 1/20 0.35
▸ TAAR1 Q96RJ0 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ PKM P14618 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1533774 0.87 RARB (0.39) RARBRARARARGMCL1ESR1
SCHEMBL1533777 0.87 RARB (0.39) RARBRARARARGMCL1ESR1
SCHEMBL1533784 0.86 RARB (0.39) RARBRARARARGMCL1ESR1
SCHEMBL24300878 0.85 FFAR4 (0.41) RARBRARARARGMCL1ESR1
SCHEMBL22872139 0.85 RARB (0.40) RARBRARARARGMCL1ESR1
SCHEMBL22872121 0.84 RARB (0.38) RARBRARARARGMCL1NPC1
SCHEMBL1533776 0.84 RARB (0.42) RARBRARARARGMCL1ESR1
SCHEMBL24300880 0.83 FFAR4 (0.41) RARBRARARARGMCL1ESR1
SCHEMBL24300863 0.83 FFAR4 (0.43) RARBRARARARGMCL1ESR1
SCHEMBL1533783 0.83 RARB (0.47) RARBRARARARGMCL1ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4279565-A2 THIOPHENE COMPOUND, LIQUID-CRYSTALLINE MEDIUM AND LIQUID-CRYSTAL DISPLAY COMPRISING THE SAME Merck Patent GmbH (DE) 2023-11-22 — — EP disclosed
EP-3763802-B1 THIOPHENE COMPOUND, LIQUID-CRYSTALLINE MEDIUM AND LIQUID-CRYSTAL DISPLAY COMPRISING THE SAME MERCK PATENT GMBH (DE) 2023-09-06 — — EP disclosed
US-11168255-B2 Thiophene compound, liquid-crystalline medium and liquid-crystal display comprising the same MERCK PATENT GMBH (DE) 2021-11-09 — — US disclosed
US-20210139779-A1 Thiophene compound, liquid-crystalline medium and liquid-crystal display comprising the same MERCK PATENT GMBH (DE) 2021-05-13 — — US disclosed
EP-3763802-A1 THIOPHENE COMPOUND, LIQUID-CRYSTALLINE MEDIUM AND LIQUID-CRYSTAL DISPLAY COMPRISING THE SAME Merck Patent GmbH (DE) 2021-01-13 — — EP disclosed
US-8394293-B2 Thiophene derivatives, and LC media containing same MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2013-03-12 — — US disclosed
US-8394293-B2 Thiophene derivatives, and LC media containing same MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2013-03-12 — — US disclosed
US-8394293-B2 Thiophene derivatives, and LC media containing same MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2013-03-12 — — US disclosed
EP-2265692-B1 THIOPHENE DERIVATIVES, AND LC MEDIA CONTAINING THE SAME MERCK PATENT GMBH (DE) 2012-07-04 — — EP disclosed
US-20110049427-A1 Thiophene derivatives, and LC media containing same MERCK PATENT GESELLSCHAFT (DE) 2011-03-03 — — US disclosed
US-20110049427-A1 Thiophene derivatives, and LC media containing same MERCK PATENT GESELLSCHAFT (DE) 2011-03-03 — — US disclosed
US-20110049427-A1 Thiophene derivatives, and LC media containing same MERCK PATENT GESELLSCHAFT (DE) 2011-03-03 — — US disclosed
EP-2265692-A1 THIOPHENE DERIVATIVES, AND LC MEDIA CONTAINING THE SAME Merck Patent GmbH (DE) 2010-12-29 — — EP disclosed
WO-2009129915-A1 THIOPHENE DERIVATIVES, AND LC MEDIA CONTAINING THE SAME MERCK PATENT GMBH (DE) 2009-10-29 — — WO disclosed
WO-2009129915-A1 THIOPHENE DERIVATIVES, AND LC MEDIA CONTAINING THE SAME MERCK PATENT GMBH (DE) 2009-10-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110049427-A1 Thiophene derivatives, and LC media containing same TPMT, TEC, LCT RARB 3984/4885RARA 4056/4885RARG 4297/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback